Claris Lifesciences trades higher despite weak numbers

01 Mar 2012 Evaluate

Claris Lifesciences is currently trading at Rs. 150.00, up by 4.60 points or 3.16% from its previous closing of Rs. 145.40 on the BSE.

The scrip opened at Rs. 144.80 and has touched a high and low of Rs. 152.50 and Rs. 144.25 respectively. So far 277777 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 199.45 on 08-Apr-2011 and a 52 week low of Rs. 98.10 on 19-Dec-2011.

Last one week high and low of the scrip stood at Rs. 156.00 and Rs. 138.20 respectively. The current market cap of the company is Rs. 960.14 crore.

The promoters holding in the company stood at 69.00% while Institutions and Non-Institutions held 23.30% and 7.70% respectively.

Claris Lifesciences’ consolidated net profit has declined by 10.70% to Rs 126.26 crore for FY11 from Rs 141.44 crore in the previous year. The company’s consolidated net sales also declined by 1.8% to Rs 738.76 crore from Rs 752.33 crore.Tts earnings per share declined to Rs 19.78 from Rs 27.34 in the last year.

The company’s board has recommended a dividend of Rs 2 per share or 20% for the year 2011.

The company has commercialized sales across 91 countries worldwide and has 1,228 product approvals out of which 207 are in the regulated market and has filed for 357 marketing authorizations under registration out of which 122 are in the regulated market.

Peers
Company Name CMP
Redington 216.95
Adani Enterprises 3263.50
Amrapali Industries 15.35
Rashi Peripheral 341.75
Compuage Infocom 3.71
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.